LIVSANE Hustenstiller Butamirat sirop

7680708910011 CH-70891 R05DB13 03.01.2.

No images available

Details

Product number
7089101
CPT
-
Packaging group
200
Unit
ml
Composition
butamirati dihydrogenocitras 1.5 mg/ml, sorbitolum liquidum non cristallisabile 415.10 mg/ml, saccharinum natricum, natrii benzoas 1.1325 mg/ml, vanillinum, acidum hydrochloridum concentratum, natrii hydroxidum, aqua purificata ad solutionem pro 1 ml corresp. natrium 0.25 mg.

Articles (1)

LIVSANE Hustenstiller Butamirat, Sirup
Sirup
200
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
butamirati dihydrogenocitras
1.5 MGML Substance Wirkstoff (Principe actif)
sorbitolum liquidum non cristallisabile
415.1 MGML Substance HBESI
saccharinum natricum
- Substance AIMDK
natrii benzoas
1.1325 MGML Substance HBESI
vanillinum
- Substance AIMDK
acidum hydrochloridum concentratum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua purificata
- Substance HNIDK
natrium
0.25 MG Substance HBESI

Authorization holder

Pharmapost AG

4704 Niederbipp

Authorization information

Swissmedic authorization number
70891
Drug name
LIVSANE Hustenstiller Butamirat, Sirup
Galenic form
SIRU
ATC Code
R05DB13
Authorization status
Z
Authorization category
Category C
Dispensation category
D
First authorization
28/07/2026
Authorization expiration date
31/12/9999
IT number
03.01.2.
Domain
Human medicine
Field of application
Husten, insbesondere trockener Husten

Packaging details

Description (FR)
LIVSANE Hustenstiller Butamirat sirop
Description (DE)
LIVSANE Hustenstiller Butamirat Sirup
Market launch
01/07/2027
Narcotic (BTM)
No
Buy us a coffee Explore the data